BrightPath Biotherapeutics Co., Ltd. (TYO:4594)
Japan flag Japan · Delayed Price · Currency is JPY
51.00
-1.00 (-1.92%)
Jul 16, 2026, 11:06 AM JST

TYO:4594 Cash Flow Statement

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2018FY 2017
Period Ending
Mar '26 Mar '25 Mar '24 Mar '18 Mar '17
Net Income
-1,305-1,151-1,168-1,573-1,116
Depreciation & Amortization
--0.47341
Loss (Gain) From Sale of Assets
-0.4----
Asset Writedown & Restructuring Costs
9.41.377.25--
Other Operating Activities
71.97-103.060.7-313
Change in Accounts Receivable
1.09-1.140.05-2251
Change in Inventory
---14-6
Change in Accounts Payable
-00.02-0.06-13-41
Change in Other Net Operating Assets
-142.963.612.82-67-9
Operating Cash Flow
-1,366-1,250-1,157-1,591-1,067
Capital Expenditures
-0.59-1.37-6.19-108-97
Cash Acquisitions
----7
Sale (Purchase) of Intangibles
---1.45-3-6
Other Investing Activities
-1.34----
Investing Cash Flow
-1.93-1.37-7.65-111-96
Long-Term Debt Issued
-500500--
Long-Term Debt Repaid
-25-587.5-387.5--
Net Debt Issued (Repaid)
-25-87.5112.5--
Issuance of Common Stock
2,7391,093578.463,2813,559
Repurchase of Common Stock
-0-1.04---
Other Financing Activities
-0-00--
Financing Cash Flow
2,7141,005690.963,2813,559
Miscellaneous Cash Flow Adjustments
-0---1-1
Net Cash Flow
1,346-246.89-473.611,5782,395
Free Cash Flow
-1,366-1,252-1,163-1,699-1,164
Free Cash Flow Margin
-1626716.67%-110479.17%-1615436.11%-479.94%-220.04%
Free Cash Flow Per Share
--15.36-18.13-44.44-34.22
Cash Income Tax Paid
-1.91.932
Levered Free Cash Flow
-892.46-836.04--1,029-
Unlevered Free Cash Flow
-892.46-836.04--1,029-
Change in Working Capital
-141.872.492.81-88-5